📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Vitaeris

1.1 - Company Overview

Vitaeris Logo

Vitaeris

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biopharmaceutical development by a Canadian company focused on the anti-interleukin-6 monoclonal antibody Clazakizumab, with global exclusive rights licensed from Alder Biopharmaceuticals, pursuing applications in chronic inflammatory diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Vitaeris

Vaxart Logo

Vaxart

HQ: United States Website
  • Description: Provider of oral vaccine pills and vaccine technology for infectious diseases, including COVID-19 (Phase II, room-temperature stable for easier global distribution), norovirus (Phase 1), influenza (Phase 1 completed for H1N1 and influenza B), RSV (targeting vulnerable populations), and an HPV therapeutic vaccine for types 16 and 18, built on the VAAST™ platform using Ad5 to deliver antigens and adjuvants to mucosal cells.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vaxart company profile →
Simcha Therapeutics Logo

Simcha Therapeutics

HQ: United States Website
  • Description: Provider of engineered cytokine immunotherapies for cancer, including ST-067, an engineered IL-18 variant designed to overcome the IL-18BP decoy receptor, in Phase 1 trials for solid tumors; ST-067 plus Keytruda® in Phase 1; preclinical ST-067 combination therapies; and undisclosed cytokine therapeutic programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Simcha Therapeutics company profile →
NextPoint Therapeutics Logo

NextPoint Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage therapeutics to treat cancer, including NPX887 targeting HHLA2 and NPX267 targeting KIR3DL3 to reactivate exhausted T and NK cells in HHLA2+ solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NextPoint Therapeutics company profile →
Calico Labs Logo

Calico Labs

HQ: United States Website
  • Description: Provider of research and development focused on the biology that controls aging and lifespan; a Google-sponsored company researching the challenges of aging and disease to diminish their effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calico Labs company profile →
Iconic Therapeutics Logo

Iconic Therapeutics

HQ: United States Website
  • Description: Provider of TF-targeting immunoconjugate proteins and monoclonal antibodies for diseases with Tissue Factor overexpression. Offers a licensed anti-TF fusion protein (hI-con1) from Yale; ophthalmology program for retinal diseases (AMD, diabetic retinopathy); inflammation program to modulate cytokines/chemokines; and an oncology program with Exelixis developing an ADC for solid tumors, in Phase I.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Iconic Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Vitaeris

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Vitaeris

2.2 - Growth funds investing in similar companies to Vitaeris

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Vitaeris

4.2 - Public trading comparable groups for Vitaeris

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Vitaeris

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Vitaeris

What does Vitaeris do?

Vitaeris is a provider of clinical-stage biopharmaceutical development by a Canadian company focused on the anti-interleukin-6 monoclonal antibody Clazakizumab, with global exclusive rights licensed from Alder Biopharmaceuticals, pursuing applications in chronic inflammatory diseases.

Who are Vitaeris's competitors?

Vitaeris's competitors and similar companies include Vaxart, Simcha Therapeutics, NextPoint Therapeutics, Calico Labs, and Iconic Therapeutics.

Where is Vitaeris headquartered?

Vitaeris is headquartered in Canada.

How many employees does Vitaeris have?

Vitaeris has 1,000 employees 🔒.

When was Vitaeris founded?

Vitaeris was founded in 2010 🔒.

What sector and industry vertical is Vitaeris in?

Vitaeris is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Vitaeris

Who are the top strategic acquirers in Vitaeris's sector and industry

Top strategic M&A buyers and acquirers in Vitaeris's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Vitaeris?

Top strategic M&A buyers groups and sectors for Vitaeris include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Vitaeris's sector and industry vertical

Which are the top PE firms investing in Vitaeris's sector and industry vertical?

Top PE firms investing in Vitaeris's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Vitaeris's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Vitaeris's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Vitaeris's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Vitaeris include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Vitaeris's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Vitaeris?

The key public trading comparables and valuation benchmarks for Vitaeris include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Vitaeris for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Vitaeris with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Vitaeris's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Vitaeris with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Vitaeris's' sector and industry vertical?

Access recent funding rounds and capital raises in Vitaeris's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Vitaeris